Intranasal Vaccine Backed by Feds—A New Control Mechanism? 🌐🔗
🚨 Get ready, folks! The University of Georgia has secured a whopping $40 million from the feds to test an intranasal vaccine against COVID-19. This new vaccine, CVXGA, is being developed by CyanVac Inc, a company led by Biao He, a prominent figure in the veterinary medicine field. He’s been on a White House panel advising on COVID-19 vaccines, and now he’s pushing forward with this new intranasal vaccine. This isn’t just about fighting the virus—this is about control! 🌐🔗
Intranasal Vaccines: A New Frontier or a New Threat? 🌬️🔍
Intranasal mucosal vaccines claim to offer superior protection by stimulating local immune responses right where the virus enters—our respiratory tract. They generate IgA antibodies to neutralize the virus at the entry point. Sounds great, right? But don’t be fooled! They’re not telling you the whole story. This is another way for Big Pharma to push their agenda. These vaccines aim to stop transmission more effectively, but what else are they doing? 😱🔗
The Promises and Perils of Mucosal Immunity 🛡️🧬
The ability of these vaccines to prevent transmission by inducing robust mucosal immunity is being hailed as a breakthrough. But at what cost? They say it will reduce viral shedding and transmission, but who is benefiting? Certainly not us! The convenience of administration and lack of need for cold chain infrastructure are just bonuses for the pharmaceutical giants. We must stay vigilant and question their true motives. 🚨🔗
The Technology Behind the Vaccine 🧪🦠
This new vaccine is based on a viral delivery platform using modified strains of parainfluenza virus 5. It’s supposedly harmless to humans but effective in generating an immune response. Professor Biao He claims this is a tribute to UGA and their support. But are we just guinea pigs in their grand experiment? These new technologies are often rushed through without thorough testing. Stay alert! ⚠️🔗
Project NextGen: Continuation of a Flawed Legacy 🚀💉
Project NextGen, Biden’s version of Trump’s Operation Warp Speed, continues to pour money into these “innovative” vaccines. Despite the end of the global emergency, the government is still funding new COVID-19 countermeasures. Why? Because the current mRNA vaccines have significant limitations. This is their way of admitting it without saying it outright. The Phase 2b study will start this fall, but we must ask ourselves: what are they really planning? 🕵️♂️🔗
Written by Dick Vegas, created by Kenny Valenzuela, experimentalvaccines.org
Here are six mainstream articles discussing the new COVID-19 nasal spray vaccine:
- “Scientists discover potential nasal COVID-19 vaccine candidate that offers better and longer protection”
ScienceDaily - “Breaking the Booster Cycle: Nasal Vaccine Offers Superior, Long-Lasting COVID-19 Immunity”
SciTechDaily - “Are COVID-19 Nasal Vaccines Really Coming?”
HealthCentral - “Novel nasal COVID-19 vaccine offers longer, better immunity than jabs”
New Atlas - “WashU COVID-19 nasal vaccine technology licensed to Ocugen”
Washington University School of Medicine in St. Louis - “COVID-19 Vaccine Nasal Spray”
JAMA Network
These articles provide a broad overview of the current research and developments in nasal COVID-19 vaccines, including their potential benefits over traditional injection methods.
Here are six clinical trials related to COVID-19 nasal spray vaccines:
- Safety, Tolerability and Immunogenicity of Gam-COVID-Vac Vaccine in a Nasal Spray
ClinicalTrials.gov - HH-120 Nasal Spray for Post-exposure Prevention of SARS-CoV-2
ClinicalTrials.gov - SA55 Novel Coronavirus Broad-spectrum Neutralizing Antibody Nasal Spray
ClinicalTrials.gov - Post-marketing Study of Lyophilized Nasal Spray Live Attenuated Influenza Vaccine
ClinicalTrials.gov - A Phase 2 Trial of the Immunogenicity and Safety of CVXGA Intranasal COVID Vaccine in Healthy Adults
ClinicalTrials.gov - Phase I Safety Study of B/HPIV3/S-6P Vaccine Via Nasal Spray in Adults
ClinicalTrials.gov
These links will provide you with detailed information on the various trials for COVID-19 nasal spray vaccines.
- FluGen Deleting Genes And Replacing Them With Live Viruses The New Vaccines 💉🦠M2SR Flu Vaccine: A Trojan Horse in the Fight Against the Flu, Or Another Trap by Big Pharma? Welcome, truth seekers! Today, we’re diving into the latest so-called “miracle” by FluGen—the M2 Deleted Single Replication Live Virus Vaccine, or M2SR. Sounds fancy, right? But before you roll up your sleeve for another jab, let’s break this down Dick Vegas-style, where […] ↓ Read the rest of this entry…
English